A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: results of NSABP protocol C-08. - Wolmark,N.; Yothers,G.; O’Connell,M.J. (J Clin Oncol, 2009)